Article: Celgene Corp. (Active Pharmaceutical Ingredient Watch).(Food and Drug Administration requires Phase III trials for Thalomid)(Brief Article)

Article: Other News To Note.(Celgene Corp., DNAPrint ...
BIOWORLD Today;  March 6, 2006 ;     700+ words ... ... respiratory tract infections that is in Phase III trials. (See BioWorld Today, March 1, 2006.) Celgene Corp., of Summit, N.J., said the FDA ... dexamethasone, and the sNDA is based on two Phase III studies demonstrating a statistically ...

Article: Celgene halts Revlimid trial.(Celgene Corp.)(Brief ...
Pharma Marketletter;  May 10, 2004 ;     518 words ...Celgene Corp of the USA has said it plans to stop a pivotal Phase III monotherapy trial of Revlimid (CC-5013; formerly Revimid) in melanoma patients. This follows a recommendation by the Data ...

Article: OTHER NEWS TO NOTE.(Applied Genetics Inc. shares purchased by ...
BIOWORLD Today;  February 11, 2005 ;     700+ words ... ... drug delivery technology. Celgene Corp., of Summit, N.J ... Chester, Pa., said that its Phase III studies of 150- and 250 ... prepares to complete its pivotal Phase III study with Thymita (nolatrexed ... will be further tested in a Phase III program focusing on certain ...

Article: Other News To Note.(Biogen Idec Inc., Celgene ...
BIOWORLD Today;  April 10, 2006 ;     700+ words ... ... Dublin, Ireland, said Phase III data reported at the ... March 9, 2006.) Celgene Corp., of Summit, N.J ... results from two pivotal Phase III trials evaluating the ... followed by a randomized Phase III trial before the end ...

Article: CELGENE'S REVLIMID NDA DONE; MYELOMA DATA DUE THIS ...
BIOWORLD Today;  April 11, 2005 ;     700+ words ... ... Coast Editor As expected, Celgene Corp. finished its rolling new ... Revlimid has been based on the Phase III [MM] scenario, and a number ... last month that a pair of Phase III trials with Revlimid in MM ... might not happen until 2006. Phase III MM studies compared ...

Article: CELGENE GETS $88M IN RE-TOOLING OF THALOMID DEAL WITH ...
BIOWORLD Today;  December 7, 2004 ;     700+ words ... ... Osborne, West Coast Editor Following Celgene Corp.'s buyout of Penn T Ltd., the worldwide ... ASH) meeting in San Diego, where Phase III data regarding thalidomide (brand named ... Celgene reported final results from a Phase III study using thalidomide plus dexamethasone ...

Article: Celgene's Revlimid MMA accepted by EMEA.(Celgene ...
Pharma Marketletter;  April 17, 2006 ;     700+ words ...US firm Celgene Corp says that the European Medicines Agency (EMEA) has accepted for review ... upon the safety and efficacy results of two large, randomized pivotal Phase III special protocol assessment trials, North American Trial MM-009 ...